Anti-Inflammatory Activity of Pyrazolo[1,5-a]quinazolines; Molecules; Vol. 29, iss. 11

Anti-Inflammatory Activity of Pyrazolo[1,5-a]quinazolines; Molecules; Vol. 29, iss. 11

Podrobná bibliografie
Parent link:	Molecules.— .— Basel: MDPI AG Vol. 29, iss. 11.— 2024.— Article number 2421, 24 p.
Další autoři:	Crocetti L. Letizia, Khlebnikov A. I. Andrey Ivanovich, Guerrini G. Gabriella, Schepetkin (Shchepyotkin) I. A. Igor Aleksandrovich, Melani F. Fabrizio, Giovannoni M. P. Maria Paola, Quinn M. T. Mark
Shrnutí:	Title screen Chronic inflammation contributes to a number of diseases. Therefore, control of the inflammatory response is an important therapeutic goal. To identify novel anti-inflammatory compounds, we synthesized and screened a library of 80 pyrazolo[1,5-a]quinazoline compounds and related derivatives. Screening of these compounds for their ability to inhibit lipopolysaccharide (LPS)-induced nuclear factor κB (NF-κB) transcriptional activity in human THP-1Blue monocytic cells identified 13 compounds with anti-inflammatory activity (IC50 < 50 µM) in a cell-based test system, with two of the most potent being compounds 13i (5-[(4-sulfamoylbenzyl)oxy]pyrazolo[1,5-a]quinazoline-3-carboxamide) and 16 (5-[(4-(methylsulfinyl)benzyloxy]pyrazolo[1,5-a]quinazoline-3-carboxamide). Pharmacophore mapping of potential targets predicted that 13i and 16 may be ligands for three mitogen-activated protein kinases (MAPKs), including extracellular signal-regulated kinase 2 (ERK2), p38α, and c-Jun N-terminal kinase 3 (JNK3). Indeed, molecular modeling supported that these compounds could effectively bind to ERK2, p38α, and JNK3, with the highest complementarity to JNK3. The key residues of JNK3 important for this binding were identified. Moreover, compounds 13i and 16 exhibited micromolar binding affinities for JNK1, JNK2, and JNK3. Thus, our results demonstrate the potential for developing lead anti-inflammatory drugs based on the pyrazolo[1,5-a]quinazoline and related scaffolds that are targeted toward MAPKs Текстовый файл
Jazyk:	angličtina
Vydáno:	2024
Témata:	pyrazolo[1,5-a]quinazoline anti-inflammatory compound mitogen-activated protein kinase c-Jun N-terminal kinase molecular docking pharmacophore mapping электронный ресурс труды учёных ТПУ
On-line přístup:	https://doi.org/10.3390/molecules29112421
Médium:	Elektronický zdroj Kapitola
KOHA link:	https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=683079

Podobné jednotky

Novel Tryptanthrin Derivatives with Selectivity as c–Jun N–Terminal Kinase (JNK) 3 Inhibitors; Molecules; Vol. 28, iss. 12
Vydáno: (2023)

Synthesis, anticancer activity, and molecular modeling of 1,4-naphthoquinones that inhibit MKK7 and Cdc25; European Journal of Medicinal Chemistry; Vol. 183
Vydáno: (2019)

Inhibitory effect of IQ-1S, a selective c-Jun N-terminal kinase (JNK) inhibitor, on phenotypical and cytokine-producing characteristics in human macrophages and T-cells; European Journal of Pharmacology; Vol. 878
Vydáno: (2020)

Neuroprotective Effects of Tryptanthrin-6-Oxime in a Rat Model of Transient Focal Cerebral Ischemia; Pharmaceuticals; Vol. 16, iss. 8
Vydáno: (2023)

Tricyclic Isatin Derivatives as Anti-Inflammatory Compounds with High Kinase Binding Affinity; Molecules; Vol. 30, iss. 14
Vydáno: (2025)

Alarmins and c-Jun N-Terminal Kinase (JNK) Signaling in Neuroinflammation; Cells; Vol. 9, iss. 11
Vydáno: (2020)

c-Jun N-Terminal Kinase (JNK) Inhibitor IQ-1S as a Suppressor of Tumor Spheroid Growth; Molecules; Vol. 30, iss. 21
Vydáno: (2025)

Design, synthesis and biological evaluation of novel O-substituted tryptanthrin oxime derivatives as c-Jun N-terminal kinase inhibitors; Frontiers in Pharmacology; Vol. 13
Vydáno: (2022)

Therapeutic Effects of Tryptanthrin and Tryptanthrin-6-Oxime in Models of Rheumatoid Arthritis; Frontiers in Pharmacology; Vol. 11
Vydáno: (2020)

Synthesis, biological evaluation, and molecular modeling of 11H-indeno[1,2-b]quinoxalin-11-one derivatives and tryptanthrin-6-oxime as c-Jun N-terminal kinase inhibitors; European Journal of Medicinal Chemistry; Vol. 161
Vydáno: (2018)

Protective Effects of a New C-Jun N-terminal Kinase Inhibitor in the Model of Global Cerebral Ischemia in Rats; Molecules; Vol. 24, iss. 9
Vydáno: (2019)

Novel c-Jun N-Terminal Kinase (JNK) Inhibitors with an 11H-Indeno[1,2-b]quinoxalin-11-one Scaffold; Molecules; Vol. 26, iss. 18
Vydáno: (2021)

c-Jun N-Terminal Kinases and Their Pharmacological Modulation in Ischemic and Reperfusion Brain Injury; Neuroscience and Behavioral Physiology; Vol. 48, iss. 6
Vydáno: (2019)

Suppression of Age-Related Macular Degeneration-like Pathology by c-Jun N-Terminal Kinase Inhibitor IQ-1S; Biomedicines; Vol. 11, iss. 2
Vydáno: (2023)

Electrosprayed poly(lactic-co-glycolic acid) particles as a promising drug delivery system for the novel JNK inhibitor IQ-1; European Polymer Journal; Vol. 127
Vydáno: (2020)

Poly(ε-caprolactone) Scaffolds Doped with c-Jun N-terminal Kinase Inhibitors Modulate Phagocyte Activation; ACS Biomaterials Science and Engineering; Vol. 5, iss. 11
Vydáno: (2019)

Regulation of Blood–Brain Barrier Permeability via JNK Signaling Pathway: Mechanisms and Potential Therapeutic Strategies for Ischemic Stroke, Alzheimer’s Disease and Brain Tumors; Molecules; Vol. 30, iss. 11
Vydáno: (2025)

c-Jun N-Terminal Kinases (JNKs) in Myocardial and Cerebral Ischemia/Reperfusion Injury; Frontiers in Pharmacology; Vol. 9
Vydáno: (2018)

Vasoactive and Neuroprotective Effects of c-Jun N-Terminal Kinase Inhibitor in Rats with Chronic Cerebral Hypoperfusion; Journal of Evolutionary Biochemistry and Physiology; Vol. 59, iss. 3
Vydáno: (2023)

Oximes: Novel Therapeutics with Anticancer and Anti-Inflammatory Potential; Biomolecules; Vol. 11, iss. 6
Vydáno: (2021)

Pyridazinones and Structurally Related Derivatives with Anti-Inflammatory Activity; Molecules; Vol. 27, iss. 12
Vydáno: (2022)

Abl silencing inhibits CAS-Mediated process and constriction in resistance arteries; Circulation Research; Vol. 101, iss. 4
Vydáno: (2007)

Effect of IQ-1 on the Infarct Size and the Parameters of Cardiodynamic Indicators in the Acute Period after Myocardial Ischemia/Reperfusion in Rats; Bulletin of Experimental Biology and Medicine; Vol. 176, iss. 4
Vydáno: (2024)

Evaluation of Nitric Oxide-Donating Properties of 11H-indeno[1,2-b]quinoxalin-11-one Oxime (IQ-1) by Electron Paramagnetic Resonance Spectroscopy; Molecules; Vol. 29, iss. 16
Vydáno: (2024)

Comparative study of anti-inflammatory and analgesic activity of diterpene alkaloid songorine obtained from Aconitum barbatum and its cell culture; Research Results in Pharmacology; Vol. 11 No. 4
Vydáno: (2025)

Neuroprotective Effects of the Lithium Salt of a Novel JNK Inhibitor in an Animal Model of Cerebral Ischemia-Reperfusion; Biomedicines; Vol. 10, iss. 9
Vydáno: (2022)

Cardioprotective Effects of a Selective c-Jun N-terminal Kinase Inhibitor in a Rat Model of Myocardial Infarction; Biomedicines; Vol. 11, iss. 3
Vydáno: (2023)

Neutrophil Immunomodulatory Activity of Natural Organosulfur Compounds; Molecules; Vol. 24, iss. 9
Vydáno: (2019)

Inhibition of T Cell Receptor Activation by Semi-Synthetic Sesquiterpene Lactone Derivatives and Molecular Modeling of Their Interaction with Glutathione and Tyrosine Kinase ZAP-70; Molecules; Vol. 24, iss. 2
Vydáno: (2019)

Synthesis, Antibacterial Properties and Molecular Docking Studies of Nitrogen Substituted 9-(((4X-But-2-ynyloxy)methyl)-1,2,3-triazolyl)–Cinchona Alkaloid Conjugates; Molecules; Vol. 30, iss. 22
Vydáno: (2025)

Antiviral Activity of (1S,9aR)-1-[(1,2,3-Triazol-1-yl)methyl]octahydro-1H-quinolizines from the Alkaloid Lupinine; Molecules; Vol. 29, iss. 23
Vydáno: (2024)

A versatile synthetic approach to various 5-alkynyl modified isatin derivatives: Cytotoxicity, acetylcholinesterase inhibition activity and molecular modeling study; Bioorganic Chemistry; Vol. 165
Vydáno: (2025)

Synthesis and In Silico Evaluation of the Ninhydrin Derivatives Interaction with Target Proteins Involved in Cancer Pathogenesis and Progression; Organics; Vol. 7, iss. 2
Autor: Kovrizhina A. R. Anastasia Ruslanovna
Vydáno: (2026)

Antioxidase-mimetic artificial biotubes for anti-inflammatory healing and regeneration of vascular injury; Biomaterials; Vol. 327
Vydáno: (2026)

6,8-Dibromo-11H-indeno[1,2-b]quinolin-11-one; Molbank; Vol. 2024, iss. 4
Vydáno: (2024)

Experimental and Computational Investigation of the Oxime Bond Stereochemistry in c-Jun N-terminal Kinase 3 Inhibitors 11H-Indeno[1,2-b]quinoxalin-11-one Oxime and Tryptanthrin-6-oxime; Pharmaceutics; Vol. 15, iss. 7
Vydáno: (2023)

Pyridinone Derivatives as Interesting Formyl Peptide Receptor (FPR) Agonists for the Treatment of Rheumatoid Arthritis; Molecules; Vol. 26, iss. 21
Vydáno: (2021)

Role of protein kinase C, PI3 kinase, tyrosine kinases, NO-synthase, KATP channels and MPT pore in the signaling pathway of the cardioprotective effect of chronic continuous hypoxia; General Physiology and Biophysics; Vol. 37, iss. 5
Vydáno: (2018)

Inhibition of Acetylcholinesterase by Novel Lupinine Derivatives; Molecules; Vol. 28, iss. 8
Vydáno: (2023)

Estimation of interaction energy of some functional groups of medical substances with protein molecules in water condition; Bulletin of the Tomsk Polytechnic University; Vol. 309, № 4
Autor: Bondarev А. А.
Vydáno: (2006)